The cancer one is interesting just because of recent statements about a Zenith partnership of some kind (which may or may not be complete BS). Given apabetalone is a sister compound to Zenith's it only makes sense there could be - maybe - possible applications in cancer.
It might be useful for Zenith to have access to one more compound that has been extensively tested in humans.